A recent study on the prognosis of immune gene-related lncRNAs and immunotherapy suggests that IPO5P1 may be a prognostically important value in bladder cancer patients as well as a predictor of the efficacy of immunotherapy [33]. The gene discussed is IPO5P1; the disease is urinary bladder carcinoma.